These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23453891)

  • 1. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.
    Müller T; van Laar T; Cornblath DR; Odin P; Klostermann F; Grandas FJ; Ebersbach G; Urban PP; Valldeoriola F; Antonini A
    Parkinsonism Relat Disord; 2013 May; 19(5):501-7 ; discussion 501. PubMed ID: 23453891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.
    Rispoli V; Simioni V; Capone JG; Golfrè Andreasi N; Preda F; Sette E; Tugnoli V; Sensi M
    Acta Neurol Scand; 2017 Dec; 136(6):660-667. PubMed ID: 28608472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.
    Merola A; Romagnolo A; Zibetti M; Bernardini A; Cocito D; Lopiano L
    Eur J Neurol; 2016 Mar; 23(3):501-9. PubMed ID: 26498913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.
    Uncini A; Eleopra R; Onofrj M
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):490-5. PubMed ID: 25168395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
    Mancini F; Comi C; Oggioni GD; Pacchetti C; Calandrella D; Coletti Moja M; Riboldazzi G; Tunesi S; Dal Fante M; Manfredi L; Lacerenza M; Cantello R; Antonini A
    Parkinsonism Relat Disord; 2014 Jan; 20(1):27-31. PubMed ID: 24099722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
    Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
    Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
    Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.
    Merola A; Zibetti M; Rizzone MG; Troiano M; Artusi CA; Angrisano S; Cocito D; Lopiano L
    Acta Neurol Scand; 2014 Jan; 129(1):e1-5. PubMed ID: 23834498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Băjenaru O; Ene A; Popescu BO; Szász JA; Sabău M; Mureşan DF; Perju-Dumbrava L; Popescu CD; Constantinescu A; Buraga I; Simu M
    J Neural Transm (Vienna); 2016 Apr; 123(4):407-14. PubMed ID: 26699635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy.
    Loens S; Chorbadzhieva E; Kleimann A; Dressler D; Schrader C
    Brain Behav; 2017 May; 7(5):e00698. PubMed ID: 28523235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.
    Buongiorno M; Antonelli F; Cámara A; Puente V; de Fabregues-Nebot O; Hernandez-Vara J; Calopa M; Pascual-Sedano B; Campolongo A; Valldeoriola F; Tolosa E; Kulisevsky J; Martí MJ
    Parkinsonism Relat Disord; 2015 Aug; 21(8):871-6. PubMed ID: 26003410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
    Zibetti M; Merola A; Artusi CA; Rizzi L; Angrisano S; Reggio D; De Angelis C; Rizzone M; Lopiano L
    Eur J Neurol; 2014 Feb; 21(2):312-8. PubMed ID: 24313838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
    Antonini A; Yegin A; Preda C; Bergmann L; Poewe W;
    Parkinsonism Relat Disord; 2015 Mar; 21(3):231-5. PubMed ID: 25585993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.
    Bohlega S; Abou Al-Shaar H; Alkhairallah T; Al-Ajlan F; Hasan N; Alkahtani K
    Eur Neurol; 2015; 74(5-6):227-36. PubMed ID: 26618531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
    Poewe W; Bergmann L; Kukreja P; Robieson WZ; Antonini A
    J Parkinsons Dis; 2019; 9(3):531-541. PubMed ID: 31282424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamins and Infusion of Levodopa-Carbidopa Intestinal Gel.
    Taher J; Naranian T; Poon YY; Merola A; Mestre T; Suchowersky O; Kulasingam V; Fasano A
    Can J Neurol Sci; 2022 Jan; 49(1):19-28. PubMed ID: 33875038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.
    Pauls KAM; Toppila J; Koivu M; Eerola-Rautio J; Udd M; Pekkonen E
    Brain Behav; 2021 Dec; 11(12):e2408. PubMed ID: 34758207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies with levodopa/carbidopa intestinal gel].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.